Stay updated on BI456906 Safety & Efficacy in NASH Clinical Trial
Sign up to get notified when there's something new on the BI456906 Safety & Efficacy in NASH Clinical Trial page.

Latest updates to the BI456906 Safety & Efficacy in NASH Clinical Trial page
- Check6 days agoChange DetectedThe page footer has been updated to reflect a newer ClinicalTrials.gov site revision version (from v3.5.2 to v3.5.3).SummaryDifference0.0%

- Check13 days agoChange DetectedRevision updated from 3.5.0 to 3.5.2.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedRemoved the term 'Non-alcoholic fatty liver disease' and the related topic 'MedlinePlus Genetics' from the page's related topics.SummaryDifference0.1%

- Check42 days agoChange DetectedRevision: v3.5.0 is now shown, replacing Revision: v3.4.3.SummaryDifference0.0%

- Check49 days agoChange DetectedAdded related topics: 'Non-alcoholic fatty liver disease' and 'MedlinePlus Genetics'.SummaryDifference0.1%

- Check56 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

Stay in the know with updates to BI456906 Safety & Efficacy in NASH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BI456906 Safety & Efficacy in NASH Clinical Trial page.